US2006134108A1PendingUtilityA1

Method for retarding or precluding Alzheimer's dementia

45
Assignee: JACKOWSKI GEORGEPriority: May 16, 2001Filed: Feb 10, 2006Published: Jun 22, 2006
Est. expiryMay 16, 2021(expired)· nominal 20-yr term from priority
Inventors:George JackowskiShirley Furesz
G01N 33/6896G01N 2800/2821G01N 33/564A61M 1/3679C12Q 1/32
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for treating a condition related to the development of Alzheimer's disease (AD) is disclosed. The method involves the removal of circulating autoantibodies of a biochemical marker or markers, specifically human glial fibrillary acidic protein (GFAP) and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH), from the sera of a patient in an amount effective to reduce or eliminate phagocytosis of astrocytic cells. The invention further includes a process of immune system modulation effective for autoantibody removal.

Claims

exact text as granted — not AI-modified
1 . A process for retarding phagocytosis of astrocytic cells comprising: 
 removing autoantibodies against glial fibrillary acidic protein (GFAP) from a body fluid;    whereby removing said autoantibodies from said body fluid retards phagocytosis of astrocytic cells.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.